Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
D000328:Adult; D000756:Anemia, Sideroblastic / Q000628:therapy; D001205:Ascorbic Acid / Q000627:therapeutic use; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007501:Iron / Q000652:urine; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000628:therapy; D013789:Thalassemia / Q000628:therapy; D065227:Transfusion Reaction
D007501:Iron; D003676:Deferoxamine; D001205:Ascorbic Acid